INOGEN INC (INGN)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for INGN
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| INGN | Director, Chief Executive Officer and President; Chief Executive Officer, President and Director | 55 | [] | [] | 2026 |
Biography sourced from the proxy statement filing.
Kevin R.M. Smith has served as our Chief Executive Officer, President and a member of our Board since November 2023. Prior to joining Inogen, Mr. Smith served as the Chief Executive Officer (CEO), President and Executive Director at Sirtex Medical Limited, a medical device company, from April 2019 to November 2023, after serving as Executive Vice President of Sales & Marketing, Americas from 2017 to 2019. Mr. Smith also served on Sirtex's Board of Directors from 2019 to 2023. From December 2021 to April 2022, Mr. Smith also served as interim President and Chief Executive Officer and Director at OncoSec Medical, Inc. (Nasdaq: ONCS), a biotechnology company, and served on its Board of Directors from 2020 to 2023. In his previous roles Mr. Smith served as Executive Vice President of Business Development at Gel-e, Inc., as Chief Commercial Officer at Sensium Healthcare, as Global Vice President of Sales & Marketing at Teleflex, and served in various sales and marketing roles in other medical device companies. Mr. Smith holds a Master of Business Administration in Global Management from University of Phoenix and a Bachelor of Science in Marketing from the University of Kentucky. Qualifications: The Board believes that Mr. Smith is qualified to serve as a director based on his extensive public company leadership experience and deep knowledge of the healthcare and medical device industries. Mr. Smith has served as Chief Executive Officer and President of Inogen since 2023 and has held senior executive roles at multiple global healthcare companies, providing him with significant experience in strategic growth, commercialization, and operational leadership. He brings valuable perspective on mergers and acquisitions, capital markets, and investor engagement, as well as experience overseeing enterprise risk management, regulatory compliance, and cybersecurity matters. Mr. Smith also contributes decades of experience in sales, marketing, and global operations, including direct experience in the home medical and respiratory sector. His industry experience and service as the Company's Chief Executive Officer support effective Board deliberations and informed oversight of the Company's strategy, performance and long term value creation.